CURRENT STATE AND PROBLEMS OF DRUG SUPPLY

2025

Closed access Metadata (CSL-JSON)
DOI 10.26787/nydha-2686-6838-2025-27-11-144-155
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Тhe article discusses the key problematic aspects of drug provision in hospitals. It is noted that the shortage of certain drugs and medical devices remains one of the most pressing issues, negatively affecting the timeliness and quality of medical care. An additional risk factor is the lack of coordination between medical staff, the pharmaceutical service, and the administration of healthcare facilities. The article emphasizes the importance of rational use of medicines and optimization of procurement activities. The author highlights the need for a comprehensive approach that includes not only financial resources but also the development of a drug provision management system based on needs analysis, transparency, and collaboration among all stakeholders. Тhe article analyzes the current problems of drug provision in inpatient settings. It emphasizes that the shortage of certain groups of medicines and medical devices continues to be a significant limiting factor for the effective functioning of medical organizations. Insufficient interdepartmental and interprofessional coordination is a significant barrier to addressing these issues, making it difficult to make timely management decisions. The article also discusses the rational use of medicines, the need to improve the procurement system, and the need to increase transparency in related procedures. In conclusion, the article emphasizes the importance of implementing a comprehensive approach to drug management based on an objective assessment of needs and resource optimization.